Chargement en cours...
Markers of resistance to anti-EGFR therapy in colorectal cancer
Epidermal growth factor receptor (EGFR) is a therapeutic target in colorectal cancer (CRC). The benefit from EGFR inhibitors appears to be limited to a subset of patients with CRC. Mechanisms of resistance to EGFR inhibitors are being identified. KRAS codon 12 activating mutation is a predominate me...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Pioneer Bioscience Publishing Company
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3712296/ https://ncbi.nlm.nih.gov/pubmed/23997942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2013.029 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|